Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-019216

Chief Executive Officer sold 29,135 shares at $4.33 ($126,257)

From the SEC's structured data for this filing

Trades in this filing

Brainard Diana · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-05-18 Sale : show line 1 in the form −29,135 $4.33 $126,257 492,165 D
Open-market sales · 29,135 sh · avg $4.33 · $126,257
Loading xslF345X03/doc4.xml…